Clinical trials
Active, not recruiting Phase 2 Inflammation trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 5 |
| 2024 | 4 |
| 2025 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 21 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 2 |
| Fasa University of Medical Sciences | 2 |
| CHU de Quebec-Universite Laval | 1 |
| Columbia University | 1 |
| Federal University of Latin American Integration | 1 |
| Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 1 |
| Herlev and Gentofte Hospital | 1 |
| Hoffmann-La Roche | 1 |
| Hunter Holmes Mcguire Veteran Affairs Medical Center | 1 |
| Massachusetts General Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Inflammation | 21 |
| Cognitive Dysfunction | 2 |
| Crohn Disease | 2 |
| Fibrosis | 2 |
| Psoriasis | 2 |
| Alzheimer Disease | 1 |
| Anemia, Iron-Deficiency | 1 |
| Atherosclerosis | 1 |
| Breast Neoplasms | 1 |
| Camurati-Engelmann Syndrome | 1 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.